Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy

por Horizon, Arash A, Joseph, Robert J, Liao, Qiming, Ross, Steven T, Pakes, Gary E
Publicado 2011

1165: SARS-COV-2 VACCINATION INDUCES A PREDOMINENTLY CLASS II (CYTOKINE EFFECTOR) T CELL RESPONSE, BUT THE CLASS I RESPONSE IS AUGMENTED BY ANTI-TNF THERAPY AND VACCINE TYPE

por Xu, Alexander, Li, Dalin, Elyanow, Rebecca, Gittelman, Rachel M., Chapman, Heidi, Prostko, John, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A., Sobhani, Kimia, Cheng, Susan, Kaplan, Ian M., Mcgovern, Dermot P.B., Merchant, Akil, Melmed, Gil, Braun, Jonathan G.
Publicado 2022

Mo1018: THE T-CELL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS OFTEN DEFICIENT IN ANTIBODY-RESPONDERS, AND AUGMENTED BY ANTI-TNF THERAPY

por Li, Dalin, Xu, Alexander, Elyanow, Rebecca, Gittelman, Rachel M., Chapman, Heidi, Prostko, John, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A., Sobhani, Kimia, Cheng, Susan, Kaplan, Ian M., Mcgovern, Dermot P.B., Merchant, Akil, Melmed, Gil, Braun, Jonathan G.
Publicado 2022

The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders

por Li, Dalin, Xu, Alexander, Mengesha, Emebet, Elyanow, Rebecca, Gittelman, Rachel M., Chapman, Heidi, Prostko, John C., Frias, Edwin C., Stewart, James L., Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A, Merin, Noah, Joung, Sandy, Botwin, Gregory J., Sobhani, Kimia, Figueiredo, Jane C., Cheng, Susan, Kaplan, Ian M., McGovern, Dermot P.B., Merchant, Akil, Melmed, Gil Y., Braun, Jonathan
Publicado 2021

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

por Li, Dalin, Xu, Alexander, Mengesha, Emebet, Elyanow, Rebecca, Gittelman, Rachel M, Chapman, Heidi, Prostko, John C, Frias, Edwin C, Stewart, James L, Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Horizon, Arash A, Merin, Noah, Joung, Sandy, Botwin, Gregory J, Sobhani, Kimia, Figueiredo, Jane C, Cheng, Susan, Kaplan, Ian M, McGovern, Dermot P B, Merchant, Akil, Melmed, Gil Y, Braun, Jonathan
Publicado 2022

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease

por Xu, Alexander M., Li, Dalin, Ebinger, Joseph E., Mengesha, Emebet, Elyanow, Rebecca, Gittelman, Rachel M., Chapman, Heidi, Joung, Sandy, Botwin, Gregory J., Pozdnyakova, Valeriya, Debbas, Philip, Mujukian, Angela, Prostko, John C., Frias, Edwin C., Stewart, James L., Horizon, Arash A., Merin, Noah, Sobhani, Kimia, Figueiredo, Jane C., Cheng, Susan, Kaplan, Ian M., McGovern, Dermot P. B., Merchant, Akil, Melmed, Gil Y., Braun, Jonathan
Publicado 2022

656: POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

por Mujukian, Angela, Li, Dalin, Debbas, Philip, Banty, Andrea, Feldman, Edward J., Ha, Christina, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Solomon, Theodore, Syal, Gaurav, Targan, Stephan R., Vasiliauskas, Eric A., Ziring, David, Bonthala, Nirupama, Hampton, Melissa, Pozdnyakova, Valeriya, Gu, Phillip, Ebinger, Joseph, Joung, Sandy, Figueiredo, Jane C., Merchant, Akil, Merin, Noah, Reckamp, Karen L., Appel, Keren, Kumar, Rashmi, Boland, Brigid, Charabaty, Aline, Chiorean, Michael V., Cohen, Erica, Flynn, Ann D., Valentine, John F., Ehrlich, Adam C., Fudman, David, Glover, Sarah C., Horizon, Arash A., Karayev, Dmitry, Kretzmann, Benjamin, Hou, Jason K., Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, McConnell, Ryan, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Nimisha, Parekh, Raffals, Laura H., Rubin, David T., Sheibani, Sarah, Siegel, Corey A., Wolf, Douglas C., Younes, Ziad H., Cheng, Susan, Braun, Jonathan G., Mcgovern, Dermot P.B., Melmed, Gil
Publicado 2022

653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION

por Li, Dalin, Xu, Alexander, Ebinger, Joseph, Debbas, Philip, Banty, Andrea, Feldman, Edward J., Ha, Christina, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Solomon, Theodore, Syal, Gaurav, Targan, Stephan R., Vasiliauskas, Eric A., Ziring, David, Bonthala, Nirupama, Hampton, Melissa, Mujukian, Angela, Pozdnyakova, Valeriya, Gu, Phillip, Joung, Sandy, Appel, Keren, Kumar, Rashmi, Boland, Brigid S., Charabaty, Aline, Chiorean, Michael V., Cohen, Erica, Damas, Oriana M., Flynn, Ann D., Valentine, John F., Ehrlich, Adam C., Fudman, David, Glover, Sarah C., Horizon, Arash A., Karayev, Dmitry, Kretzmann, Benjamin, Hou, Jason K., Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, McConnell, Ryan, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Parekh, Nimisha K., Raffals, Laura H., Rubin, David T., Sheibani, Sarah, Siegel, Corey A., Wolf, Douglas C., Younes, Ziad H., Kaplan, Ian M., Prostko, John, Sobhani, Kimia, Merchant, Akil, Cheng, Susan, Braun, Jonathan G., Mcgovern, Dermot P.B., Melmed, Gil
Publicado 2022